Health and Social Care Committee

Impact of a no deal Brexit on health and social care inquiry

Inquiry status: open

Inquiry announced on Monday 17 September 2018. Oral evidence ongoing.

Scope of the inquiry

The Health and Social Care Committee will be holding an evidence session in October on the impact of a no-deal Brexit on health and social care.

Terms of Reference

 Ahead of the session, the Committee is inviting written submissions from all interested parties, setting out:

  • What the impact of a no-deal Brexit* is likely to be on their sector of the health and social care system (whether that be patients, suppliers to the health and social care system, providers of NHS or social care services, NHS or social care staff, or others).
  • Specifically, what the risks are to patients and to the health and social care system of leaving the European Union without a withdrawal agreement. The Committee would be particularly pleased to hear from patient representative groups about the extent of the potential risk to patient care of any disruption to the supply from the EU-27 to the UK of medicines, medical devices or substances of human origin.
  • How effectively stakeholders are planning for the possibility of a no-deal Brexit.
  • How effectively they consider the Government is planning for such an outcome.
  • What further planning, or reassurances, are required in order to ensure that the impact of a no-deal Brexit on health and social care would be minimised.
Terms of reference:

Latest evidence

  • 23 Oct 2018 - Impact of a no deal Brexit on health and social care - oral evidence | PDF version (PDF370 KB) HC 1583 | Published 29 Oct 2018

    Evidence given by Saffron Cordery, Deputy Chief Executive, NHS Providers, Professor Tamara Hervey, Jean Monnet Professor of European Union Law, University of Sheffield, Mike Thompson, Chief Executive, Association of British Pharmaceutical Industry, Martin Sawer, Executive Director, Healthcare Distribution Association, Mark Lloyd Davies, Senior Director, Medical Devices and Consumer Medical Technologies, Europe, Middle East and Africa, Johnson & JohnsonRt Hon Matt Hancock MP, Secretary of State for Health and Social Care, Sir Chris Wormald, Permanent Secretary, Department of Health and Social Care

Next meeting(s)

There are currently no public meetings scheduled.

News

Receive RSS updates

Share this page